See related research by Bagnato *et al*., <http://arthritis-research.com/content/15/5/R120>

Correction
==========

After publication of our recent article \[[@B1]\], we noticed that Figure 2A was incorrect as a result of mislabeling of the image files. The correct Figure 2 is given in full here as Figure [1](#F1){ref-type="fig"}.

![**Immunostaining for α-SMA in cutaneous samples.** Representative tissue sample from: **(A)** Sham animal; **(B)** HOCl mice; **(C)** HOCl + PTU animal (original magnification, ×40). The arrows show strong diffuse staining of myofibroblast nuclei (dark brown staining). **(D)** Number of myofibroblasts from the three experimental groups (HOCl + PTU group, n = 10; HOCl group, n = 10; Sham, n = 5). The increase of myofibroblast population in the skin of HOCl mice is prevented by propylthiouracil administration. Values are expressed as the mean and standard deviation. \*P \<0.001 versus Sham; \#P \<0.001 versus HOCl. α-SMA, alpha-smooth muscle actin; HOCl, hypochlorous acid; HPF, high-powered field; PTU, propylthiouracil.](ar4534-1){#F1}
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